Showing 471-480 of 1742 results for "".
- Epilepsy Care: Can We Succeed with Monotherapy?https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0405CvrStry-pdf/31461/Advancements and Challenges in Antiepileptic Drug MonotherapyIn the realm of epilepsy management, achieving seizure freedom remains the primary goal for neurologists and patients alike. Approximately 60-70% of newly diagnosed epilepsy patients achieve control with a single antiepileptic drug (AED),
Neuro-Ophthalmology Notions: The Optic Nerve as Topographic Marker in the 2024 McDonald Diagnostic Criteria for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuro-ophthalmology-notions-the-optic-nerve-as-topographic-marker-in-the-2024-mcdonald-diagnostic-criteria-for-multiple-sclerosis/35447/Neuro-ophthalmic evaluations assist in early diagnosis of multiple sclerosis.- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1206Epilepsy-pdf/31237/The Role of Generic Antiepileptic Drugs in Epilepsy ManagementEffective epilepsy treatment aims to achieve seizure freedom without adverse side effects. According to Kwan and Brodie, approximately 64% of patients reach this goal using either monotherapy or a combination of two antiseizure medication
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31344/In February 2006, Practical Neurology highlighted several pivotal developments impacting the neurology field. Notably, Congress approved a budget-cutting bill that President Bush signed into law on February 6th, effectively freezing the Medicare physician reimbursement rates at 2005 levels by haltin
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0805Epilepsy-pdf/31417/Since the 1990s, the Food and Drug Administration has approved numerous new antiepileptic drugs (AEDs) and innovative formulations of existing medications, significantly expanding the therapeutic arsenal for epilepsy management. This proliferation of treatment options holds promise for enhancing the
New and Emerging Therapies in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/new-and-emerging-therapies-in-parkinsons-disease/30473/As the therapeutic landscape expands, an increasing range of options and a promising horizon will improve management of motor fluctuations for many patients with Parkinson's disease.Diagnosing and Treating Co-morbid Sleep Apnea in Neurological Disorders, Part II
https://practicalneurology.com/diseases-diagnoses/sleep/diagnosing-and-treating-co-morbid-sleep-apnea-in-neurological-disorders-part-ii/30837/It is crucial for physicians to identify sleep apnea when it co-exists with common neurologic conditions and to be prepared to offer effective interventions.Expert Opinion: Differential Diagnosis of Isolated Elbow Pain and Treatment in Patients with Medial or Lateral Epicondylitis, Part 2
https://practicalneurology.com/diseases-diagnoses/headache-pain/differential-diagnosis-of-isolated-elbow-pain-and-treatment-in-patients-with-medial-or-lateral-epicondylitis-part-2/30624/This two-part series reviews the causes, diagnosis, and treatment of elbow pain.Recognizing and Responding to Comorbidities in MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/recognizing-and-responding-to-comorbidities-in-ms/30678/MS patients may be at increased risk for certain psychiatric and physical comorbidities. Neurologists can help identify and manage these conditions.A Comprehensive Approach to Managing Dementia Patients: Considering the Caregivers
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-comprehensive-approach-to-managing-dementia-patients-considering-the-caregivers/30777/A Q&A with Richard Isaacson, MD